Details of the Drug Reposition

General Information of This Drug (ID: DMW8C1D)

Drug Name
ADXS-HER2   DMW8C1D
Synonyms Lovaxin B; ADXS31-164; Her2/neu cancer vaccine (Listeria vector), Advaxis

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Breast cancer DIS7DPX1 2C60-2C65 Phase 1/2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02386501) Dose Escalation Study of ADXS31-164 in Subjects With HER2 Expressing Solid Tumors. U.S. National Institutes of Health.